These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23408061)

  • 61. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
    Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
    Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
    Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
    Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Calcitonin as Biomarker for the Medullary Thyroid Carcinoma.
    Bae YJ; Schaab M; Kratzsch J
    Recent Results Cancer Res; 2015; 204():117-37. PubMed ID: 26494386
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
    Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Presurgical assessment of the tumor burden of familial medullary thyroid carcinoma by calcitonin testing.
    Pomares FJ; Rodríguez JM; Nicolás F; Sola J; Canteras M; Balsalobre M; Pascual M; Parrilla P; Tébar FJ
    J Am Coll Surg; 2002 Nov; 195(5):630-4. PubMed ID: 12437249
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety.
    Mian C; Perrino M; Colombo C; Cavedon E; Pennelli G; Ferrero S; De Leo S; Sarais C; Cacciatore C; Manfredi GI; Verga U; Iacobone M; De Pasquale L; Pelizzo MR; Vicentini L; Persani L; Fugazzola L
    J Clin Endocrinol Metab; 2014 May; 99(5):1656-64. PubMed ID: 24552221
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Baseline and stimulated calcitonin: Thresholds for the diagnosis of medullary thyroid cancer.
    Fugazzola L
    Ann Endocrinol (Paris); 2019 Jun; 80(3):191-192. PubMed ID: 31053250
    [No Abstract]   [Full Text] [Related]  

  • 68. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests.
    Telenius-Berg M; Almqvist S; Berg B; Hedner P; Ingemansson S; Tibblin S; Wasthed B
    Eur J Clin Invest; 1977 Feb; 7(1):7-16. PubMed ID: 402280
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
    Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
    Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Usefulness of Serum Calcitonin in Patients Without a Suspicious History of Medullary Thyroid Carcinoma and with Thyroid Nodules Without an Indication for Fine-Needle Aspiration or with Benign Cytology.
    Rosario PW; Calsolari MR
    Horm Metab Res; 2016 Jun; 48(6):372-276. PubMed ID: 27203410
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland.
    Wells SA; Baylin SB; Linehan WM; Farrell RE; Cox EB; Cooper CW
    Ann Surg; 1978 Aug; 188(2):139-41. PubMed ID: 686877
    [TBL] [Abstract][Full Text] [Related]  

  • 72. When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
    Niccoli-Sire P; Murat A; Rohmer V; Gibelin H; Chabrier G; Conte-Devolx B; Visset J; Ronceray J; Jaeck D; Henry JF; Proye C; Carnaille B; Kraimps JL;
    Surgery; 2003 Dec; 134(6):1029-36; discussion 1036-7. PubMed ID: 14668737
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predictive Value of Calcium Test for Preoperative Diagnosis of Medullary Thyroid Carcinoma in Patients With Moderately Elevated Basal Calcitonin.
    Tausanovic KM; Zivaljevic VR; Zorić GV; Jovanovic MD; Stepanovic BG; Milenkovic MG; Paunovic IR
    Endocr Pract; 2021 Nov; 27(11):1077-1081. PubMed ID: 34216799
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Is thyrotropin-releasing hormone as reliable a calcitonin stimulant as pentagastrin in medullary thyroid carcinoma?
    Ahuja S
    Acta Endocrinol (Copenh); 1990 May; 122(5):640-2. PubMed ID: 2112816
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pentagastrin promotes prolactin release in patients with medullary carcinoma of the thyroid.
    Malarkey WB; Reynolds JC; O'Dorisio TM; Sizemore GW
    Metabolism; 1984 May; 33(5):439-42. PubMed ID: 6144034
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease.
    Rink T; Truong PN; Schroth HJ; Diener J; Zimny M; Grünwald F
    Thyroid; 2009 Apr; 19(4):327-32. PubMed ID: 19355822
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.
    McHenry CR; Oppenheim DS; Murphy T; Broughan T; Vogt D; Goldfarb WB
    Surgery; 1992 Oct; 112(4):728-32; discussion 732-3. PubMed ID: 1411944
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mild persistent hypercalcitoninemia after total thyroidectomy in patients with papillary thyroid carcinoma.
    Yokoi K; Imai T; Shibata A; Hibi Y; Kikumori T; Funahashi H; Nakao A
    Endocr J; 2003 Aug; 50(4):453-8. PubMed ID: 14599120
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma.
    Wells SA; Haagensen DE; Linehan WM; Farrell RE; Dilley WG
    Cancer; 1978 Sep; 42(3 Suppl):1498-503. PubMed ID: 709521
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
    Machens A; Dralle H
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2655-63. PubMed ID: 20339026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.